Exogenous steroid substrate modifies the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estradiol production of human luteinized granulosa cells in vitro

F. M. Morán, P. Lohstroh, C. A. VandeVoort, J. Chen, J. W. Overstreet, Alan J Conley, Bill L. Lasley

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The in vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on steroid metabolism in human luteinized granulosa cells (hLGC) have been summarized as a decreased estradiol (E2) production without altering either E2 metabolism or cytochrome P450 aromatase activity. In the present study, hLGC were used to analyze the fate of different substrates for cytochrome P450 17α-hydroxylase/17,20-lyase (P450c17) in the presence or absence of TCDD. Human LGCs were plated directly on plastic culture dishes in medium supplemented with 2 IU/ml of hCG. TCDD (10 nM) or its solvent was added directly to the cells at the time of medium change, every 48 h for 8 days. The objective of the experiment was to test the hypothesis that exogenous steroid, substrate for P450c17, would reduce the TCDD effects on E2 synthesis. With dehydroepiandrosterone (DHEA) (a P450c17 product), a dose-related increase in E2 production was observed and the effect of TCDD on lowering E2 production disappeared. In contrast, with increasing doses, up to 10 μM, of pregnenolone (P5), no change in E2 production was observed. However, 17α-hydroxypregnenolone (17P5) at 10 μM produced a modest but significant increase in the E2 production. Treatments with P5 and 17P5 did not alter the effect of TCDD on E2 production. Radiolabeled substrate utilization by hLGC suggests that the principal metabolic pathway for Δ5 substrates is the conversion to a Δ4 product probably by a very active 3βhydroxysteroid dehydrogenase. We conclude that estrogen production by hLGC is limited at the level of lyase activity. Thus, these data suggest that the most likely target for the TCDD-induced inhibition of estrogen synthesis by hLGC is the 17,20-lyase activity of the P450c17 enzyme complex.

Original languageEnglish (US)
Pages (from-to)244-251
Number of pages8
JournalBiology of Reproduction
Volume68
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Granulosa Cells
Estradiol
Steroids
Steroid 17-alpha-Hydroxylase
Cytochrome P-450 Enzyme System
Estrogens
17-alpha-Hydroxypregnenolone
Pregnenolone
Lyases
Aromatase
Dehydroepiandrosterone
Mixed Function Oxygenases
Metabolic Networks and Pathways
In Vitro Techniques
Polychlorinated Dibenzodioxins
Plastics
Oxidoreductases
Enzymes

Keywords

  • Granulosa cells
  • Steroid hormones
  • Toxicology

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Embryology

Cite this

Exogenous steroid substrate modifies the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estradiol production of human luteinized granulosa cells in vitro. / Morán, F. M.; Lohstroh, P.; VandeVoort, C. A.; Chen, J.; Overstreet, J. W.; Conley, Alan J; Lasley, Bill L.

In: Biology of Reproduction, Vol. 68, No. 1, 01.01.2003, p. 244-251.

Research output: Contribution to journalArticle

Morán, F. M. ; Lohstroh, P. ; VandeVoort, C. A. ; Chen, J. ; Overstreet, J. W. ; Conley, Alan J ; Lasley, Bill L. / Exogenous steroid substrate modifies the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estradiol production of human luteinized granulosa cells in vitro. In: Biology of Reproduction. 2003 ; Vol. 68, No. 1. pp. 244-251.
@article{fde6f2e3e4744bc7990ea80138f4261d,
title = "Exogenous steroid substrate modifies the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estradiol production of human luteinized granulosa cells in vitro",
abstract = "The in vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on steroid metabolism in human luteinized granulosa cells (hLGC) have been summarized as a decreased estradiol (E2) production without altering either E2 metabolism or cytochrome P450 aromatase activity. In the present study, hLGC were used to analyze the fate of different substrates for cytochrome P450 17α-hydroxylase/17,20-lyase (P450c17) in the presence or absence of TCDD. Human LGCs were plated directly on plastic culture dishes in medium supplemented with 2 IU/ml of hCG. TCDD (10 nM) or its solvent was added directly to the cells at the time of medium change, every 48 h for 8 days. The objective of the experiment was to test the hypothesis that exogenous steroid, substrate for P450c17, would reduce the TCDD effects on E2 synthesis. With dehydroepiandrosterone (DHEA) (a P450c17 product), a dose-related increase in E2 production was observed and the effect of TCDD on lowering E2 production disappeared. In contrast, with increasing doses, up to 10 μM, of pregnenolone (P5), no change in E2 production was observed. However, 17α-hydroxypregnenolone (17P5) at 10 μM produced a modest but significant increase in the E2 production. Treatments with P5 and 17P5 did not alter the effect of TCDD on E2 production. Radiolabeled substrate utilization by hLGC suggests that the principal metabolic pathway for Δ5 substrates is the conversion to a Δ4 product probably by a very active 3βhydroxysteroid dehydrogenase. We conclude that estrogen production by hLGC is limited at the level of lyase activity. Thus, these data suggest that the most likely target for the TCDD-induced inhibition of estrogen synthesis by hLGC is the 17,20-lyase activity of the P450c17 enzyme complex.",
keywords = "Granulosa cells, Steroid hormones, Toxicology",
author = "Mor{\'a}n, {F. M.} and P. Lohstroh and VandeVoort, {C. A.} and J. Chen and Overstreet, {J. W.} and Conley, {Alan J} and Lasley, {Bill L.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1095/biolreprod.102.007161",
language = "English (US)",
volume = "68",
pages = "244--251",
journal = "Biology of Reproduction",
issn = "0006-3363",
publisher = "Society for the Study of Reproduction",
number = "1",

}

TY - JOUR

T1 - Exogenous steroid substrate modifies the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estradiol production of human luteinized granulosa cells in vitro

AU - Morán, F. M.

AU - Lohstroh, P.

AU - VandeVoort, C. A.

AU - Chen, J.

AU - Overstreet, J. W.

AU - Conley, Alan J

AU - Lasley, Bill L.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - The in vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on steroid metabolism in human luteinized granulosa cells (hLGC) have been summarized as a decreased estradiol (E2) production without altering either E2 metabolism or cytochrome P450 aromatase activity. In the present study, hLGC were used to analyze the fate of different substrates for cytochrome P450 17α-hydroxylase/17,20-lyase (P450c17) in the presence or absence of TCDD. Human LGCs were plated directly on plastic culture dishes in medium supplemented with 2 IU/ml of hCG. TCDD (10 nM) or its solvent was added directly to the cells at the time of medium change, every 48 h for 8 days. The objective of the experiment was to test the hypothesis that exogenous steroid, substrate for P450c17, would reduce the TCDD effects on E2 synthesis. With dehydroepiandrosterone (DHEA) (a P450c17 product), a dose-related increase in E2 production was observed and the effect of TCDD on lowering E2 production disappeared. In contrast, with increasing doses, up to 10 μM, of pregnenolone (P5), no change in E2 production was observed. However, 17α-hydroxypregnenolone (17P5) at 10 μM produced a modest but significant increase in the E2 production. Treatments with P5 and 17P5 did not alter the effect of TCDD on E2 production. Radiolabeled substrate utilization by hLGC suggests that the principal metabolic pathway for Δ5 substrates is the conversion to a Δ4 product probably by a very active 3βhydroxysteroid dehydrogenase. We conclude that estrogen production by hLGC is limited at the level of lyase activity. Thus, these data suggest that the most likely target for the TCDD-induced inhibition of estrogen synthesis by hLGC is the 17,20-lyase activity of the P450c17 enzyme complex.

AB - The in vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on steroid metabolism in human luteinized granulosa cells (hLGC) have been summarized as a decreased estradiol (E2) production without altering either E2 metabolism or cytochrome P450 aromatase activity. In the present study, hLGC were used to analyze the fate of different substrates for cytochrome P450 17α-hydroxylase/17,20-lyase (P450c17) in the presence or absence of TCDD. Human LGCs were plated directly on plastic culture dishes in medium supplemented with 2 IU/ml of hCG. TCDD (10 nM) or its solvent was added directly to the cells at the time of medium change, every 48 h for 8 days. The objective of the experiment was to test the hypothesis that exogenous steroid, substrate for P450c17, would reduce the TCDD effects on E2 synthesis. With dehydroepiandrosterone (DHEA) (a P450c17 product), a dose-related increase in E2 production was observed and the effect of TCDD on lowering E2 production disappeared. In contrast, with increasing doses, up to 10 μM, of pregnenolone (P5), no change in E2 production was observed. However, 17α-hydroxypregnenolone (17P5) at 10 μM produced a modest but significant increase in the E2 production. Treatments with P5 and 17P5 did not alter the effect of TCDD on E2 production. Radiolabeled substrate utilization by hLGC suggests that the principal metabolic pathway for Δ5 substrates is the conversion to a Δ4 product probably by a very active 3βhydroxysteroid dehydrogenase. We conclude that estrogen production by hLGC is limited at the level of lyase activity. Thus, these data suggest that the most likely target for the TCDD-induced inhibition of estrogen synthesis by hLGC is the 17,20-lyase activity of the P450c17 enzyme complex.

KW - Granulosa cells

KW - Steroid hormones

KW - Toxicology

UR - http://www.scopus.com/inward/record.url?scp=0037232924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037232924&partnerID=8YFLogxK

U2 - 10.1095/biolreprod.102.007161

DO - 10.1095/biolreprod.102.007161

M3 - Article

C2 - 12493720

AN - SCOPUS:0037232924

VL - 68

SP - 244

EP - 251

JO - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 1

ER -